XML 104 R119.htm IDEA: XBRL DOCUMENT v2.4.0.8
Shareholders' Equity (Narrative) (Details) (USD $)
In Thousands, except Share data, unless otherwise specified
 1 Months Ended 12 Months Ended 1 Months Ended 12 Months Ended 12 Months Ended
Nov. 30, 2012
Nov. 30, 2011
Dec. 31, 2013
Dec. 31, 2012
Dec. 31, 2011
Sep. 30, 2011
Dec. 31, 2010
Nov. 30, 2011
2007 Stock Option Plan
Jan. 31, 2007
2007 Stock Option Plan
Dec. 31, 2013
2007 Stock Option Plan
Dec. 31, 2013
Elbit Systems' Stock Options Plans
Jan. 31, 2007
Elbit Systems' Stock Options Plans
Jan. 31, 2007
Regular Options
2007 Stock Option Plan
Jan. 31, 2007
Cashless Options
2007 Stock Option Plan
Dec. 31, 2013
Stock Appreciation Rights (SARs)
Dec. 31, 2013
Phantom Options
Dec. 31, 2012
Phantom Options
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]                                  
Options vested period from the date of grant, years               6 years 5 years                
Options exercisable     190,300 1,271,266 1,292,806             1,250,000 1,250,000 1,250,000      
Period measuring the average closing price, in days                               30 days  
Percent vested and exercisable from the second anniversary of the commencement date     50.00%                            
Additional percentage vested and exercisable from the third anniversary of the commencement date     25.00%                            
Remaining percentage vested and exercisable from the third anniversary of the commencement date     25.00%                            
Options expiration date   2013                              
Options available for future grant under the Plan                   73,926              
Compensation expense $ 2,400 $ 980                           $ 5,055 $ 312
Aggregate intrinsic value of outstanding options     3,378 4,294                          
Total intrinsic value of options exercised     29,663                            
Total unrecognized compensation cost related to share-based compensation arrangements granted                     592            
Expected cost recognition period, in years     2 years                            
Options vested and expected to be vested     267,167                            
Options, outstanding, weighted average exercise price     $ 48.09 $ 36.95 $ 37.07   $ 35.96                    
Aggregate intrinsic value of exercisable options     3,371                            
Options vested and expected to be vested, weighted average exercise price     $ 48.09                            
Compensation expense recognized in income statement     440 3,028 1,996                        
Stock repurchase program, number of shares authorized to be repurchased           1,000,000                      
Stock repurchased during period, shares     0 759,632 240,368                        
Treasury stock, value, acquired       $ 26,006 $ 10,101                        
Percent of SARs granted that are exercisable on the first anniversary of the grant date     25.00%                            
Additional percentages of SARs that are exercisable on each of the three subsequent anniversaries after the first anniversary     25.00%                            
Period from grant date each tranche has a benefit accumulation period, in years                               3 years  
Maximum term of SAR from the grant date, years                             5 years    
SARs outstanding number                             9,000,000    
SARs, number vested                             9,000    
SARs, weighted average exercise price per share                             $ 52.16    
SARs, expired                             21,000,000    
Options allocated for Plan                               1,078,507  
Available for grant, basic price                               $ 40.51  
Percentage limited increase of benefit to be paid in the share price                               100.00%